Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs77447765 | chr12:56690662 | G/A | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs7745632 | chr6:26567442 | T/C | 7.54E-7 | 176 | 10.68 | 35.32 | 24.52 | KM Plot |
PCPG | rs77522907 | chr16:90024447 | T/C | 1.26E-8 | 172 | 25.67 | 20.2 | 6.62 | KM Plot |
PCPG | rs7754998 | chr6:131711382 | C/G | 7.3E-6 | 174 | 15.33 | 28.3 | 24.7 | KM Plot |
PCPG | rs77568099 | chr16:86460651 | A/C | 0 | 174 | 25.4 | 30.18 | 3.17 | KM Plot |
PCPG | rs77571847 | chr8:121477058 | T/C | 4.11E-6 | 178 | 27.23 | 25 | 19.87 | KM Plot |
PCPG | rs77588533 | chr5:171531164 | T/C | 0.000114 | 177 | 25.87 | 22.3 | 17.12 | KM Plot |
PCPG | rs7760655 | chr6:150406493 | C/T | 3.96E-7 | 178 | 2.5 | 24.7 | 25.87 | KM Plot |
PCPG | rs77632445 | chr16:90083021 | G/A | 1.14E-8 | 174 | 25.87 | 20.2 | 6.62 | KM Plot |
PCPG | rs77637295 | chr17:1441756 | C/G | 1.14E-5 | 178 | 24.7 | 26.73 | 25.17 | KM Plot |
PCPG | rs77674256 | chr7:33700132 | G/A | 1.12E-7 | 177 | 25.28 | 25.43 | 19.87 | KM Plot |
PCPG | rs7768957 | chr6:122594090 | C/A | 5.97E-6 | 174 | 27.3 | 23.43 | 19.87 | KM Plot |
PCPG | rs77692353 | chr16:56417805 | T/C | 0 | 178 | 25.4 | 28.2 | 3.17 | KM Plot |
PCPG | rs77699179 | chr12:124092437 | G/A | 4.04E-5 | 177 | 25.87 | 19.87 | 20.13 | KM Plot |
PCPG | rs77712395 | chr16:71584527 | TA/T | 1.16E-7 | 170 | 24.47 | 30.93 | 19.87 | KM Plot |